Ultrasonic Preparation of the Implant Site in the All-on-Four Technique With Trans-sinus Implants

International Piezosurgery Academy1 site in 1 countryOctober 31, 2017

ConditionsBone Atrophy, Alveolar

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Bone Atrophy, Alveolar
Sponsor: International Piezosurgery Academy
Locations: 1
Primary Endpoint: survival rate
Status: Withdrawn
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of this observational study is the radiographic evaluation of marginal bone remodeling after surgical implant insertion in an immediate loading all-on-four technique with trans-sinusal titanium implants, correlating the gingival thickness and the height of the implant prosthetic stump with the proportion of the abovementioned marginal bone remodeling.

Detailed Description

The extent of marginal bone remodeling around the neck of dental implants has been used for many years as a criterion for defining its long-term success. In fact, the etiology of this Marginal Bone Loss has not yet been well understood, although many theories have been proposed to explain it. The influence of the thickness of the mucous membrane on marginal bone loss was discussed elsewhere which suggests a protective action for the underlying soft tissue that recreates a kind of "biological amplitude" around the implant. Some studies have suggested that a marginally oscillating bone loss between 1.5 and 2.0 mm provides the vertical space for proper restoration of the biological amplitude. Some authors. published a study that demonstrated that, in crestal systems with switching platforms, a vertical thickness of soft tissue greater than 2 mm is effective in preventing periimplant crestal bone loss. However, the severity of the sample examined precludes the possibility of making definitive conclusions. Recently other authors have shown significant marginal bone loss around implants with lower prosthetic implants than those with higher prosthetic prostheses, without however measuring the thickness of soft tissues and evaluating their influence. In particular, the extent of bone loss was extremely limited when the height of the stump was equal to or greater than 2 mm. From a theoretical point of view, a prosthetic abutment of at least 2 mm high, calculated from the apical margin of the crown to the platform of the implant, should provide adequate space for restoring the biological amplitude. It can therefore be hypothesized that these two factors (the vertical thickness of soft tissues and the height of the prosthetic stump) are the expression of the same principle: the restoration of the biological amplitude around the implant's neck. From a clinical point of view it will be useful to determine which of the two factors is most important in preventing and limiting periimplant bone loss.

Registry

clinicaltrials.gov

Start Date

October 31, 2017

End Date

February 15, 2020

Last Updated

5 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

International Piezosurgery Academy

Responsible Party

Principal Investigator

Mr. Claudio Stacchi, DDS, MSc

President of the International Piezosurgery Academy

International Piezosurgery Academy

Eligibility Criteria

Inclusion Criteria

•indications for implant insertion into the maxillary upper jaw, based on a careful diagnosis and treatment plan;
•presence of a residual bone crest with a minimum surgical height of 4 mm at the maxillary sinus (bilaterally), and a thickness of at least 6 mm at the two distally programmed implant sites;
•presence of a residual bone crest with a minimum surgical height of 10 mm at the anterior maxilla, and a thickness of at least 6 mm at the mesially programmed implant sites;
•the bone crest should be healed (at least 6 months after the loss / extraction of the corresponding dental element);
•no regenerated bone;
•Plaque index below 25% and bleeding index less than 20%;
•the buccal length of the adherent gingiva ≥ 4 mm;
•age of the patient\> 18 years;
•systemic condition of the compensated patient (American Society of Anesthesiologist score \< 2);
•Patients should be able to examine and understand the protocol of study; 9) subscribing to informed consent.